Living with early Parkinson's disease? A clinical trial is exploring a more personalized approach to treatment

(BPT) - When Tony Hindhaugh was diagnosed with Parkinson's disease at age 55, he learned that there are currently no approved therapies that slow the progression of the disease. Current treatments focus primarily on managing symptoms of the progressive brain disorder, leaving patients and families hoping for new options.

That's why he was interested in NEULARK, a new study for people with early Parkinson's who haven't started medication for their symptoms yet.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.